In T2D, gut microbial dysbiosis, including changes in the resistome, resulted in reduced SCFA production, impairing PYY and GLP‐1 secretion, which are vital for insulin regulation and glucagon levels (Figure 4a) (Zhang, Chu, et al., 2021). The gene discussed is GCG; the disease is type 2 diabetes mellitus.